BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15344188)

  • 1. Improved confidence intervals for a binomial parameter following a group sequential phase II clinical trial.
    Chang MN
    Stat Med; 2004 Sep; 23(18):2817-26. PubMed ID: 15344188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A discrete-continuous mixture quantile function estimator with a practical application to phase II cancer clinical trials.
    Hutson AD
    Stat Med; 2008 May; 27(12):2094-109. PubMed ID: 18038447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-sample confidence sets for the MTD in a phase I clinical trial.
    Storer BE
    Biometrics; 1993 Dec; 49(4):1117-25. PubMed ID: 8117905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
    Cheng Y; Shen Y
    Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constructing binomial confidence intervals with near nominal coverage by adding a single imaginary failure or success.
    Borkowf CB
    Stat Med; 2006 Nov; 25(21):3679-95. PubMed ID: 16381080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robustness of an odds-ratio test in a stratified group sequential trial with a binary outcome measure.
    Srivastava DK; Rai SN; Pan J
    Biom J; 2007 Jun; 49(3):351-64. PubMed ID: 17623341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative designs of phase II trials considering response and toxicity.
    Jin H
    Contemp Clin Trials; 2007 Jul; 28(4):525-31. PubMed ID: 17428744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the estimation of the binomial probability in multistage clinical trials.
    Jung SH; Kim KM
    Stat Med; 2004 Mar; 23(6):881-96. PubMed ID: 15027078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated confidence intervals for adaptive group sequential trials.
    Mehta CR; Bauer P; Posch M; Brannath W
    Stat Med; 2007 Dec; 26(30):5422-33. PubMed ID: 17918195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early stopping clinical trials of binomial response with an exact group sequential method.
    Zhao Z
    Stat Med; 2007 Apr; 26(8):1724-9. PubMed ID: 17206748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive probability early termination plans for phase II clinical trials.
    Herson J
    Biometrics; 1979 Dec; 35(4):775-83. PubMed ID: 526523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the design of phase II trials of cytostatic anticancer agents.
    Stone A; Wheeler C; Barge A
    Contemp Clin Trials; 2007 Feb; 28(2):138-45. PubMed ID: 16843736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses.
    Jennison C; Turnbull BW
    Biometrics; 1993 Mar; 49(1):31-43. PubMed ID: 8513110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-value calculation for multistage phase II cancer clinical trials.
    Jung SH; Owzar K; George SL; Lee T
    J Biopharm Stat; 2006; 16(6):765-75; discussion 777-83. PubMed ID: 17146978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple and efficient bias-reduced estimator of response probability following a group sequential phase II trial.
    Guo HY; Liu A
    J Biopharm Stat; 2005; 15(5):773-81. PubMed ID: 16078384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods of joint evaluation of efficacy and toxicity in phase II clinical trials.
    Tournoux C; De Rycke Y; Médioni J; Asselain B
    Contemp Clin Trials; 2007 Jul; 28(4):514-24. PubMed ID: 17331808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stat bite: Treatment trials in the PDQ clinical trials database, by phase.
    J Natl Cancer Inst; 2004 Sep; 96(18):1355. PubMed ID: 15367566
    [No Abstract]   [Full Text] [Related]  

  • 18. Coupled error spending functions for parallel bivariate sequential tests.
    Cook RJ
    Biometrics; 1996 Jun; 52(2):442-50. PubMed ID: 8672698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One- and two-stage designs for phase II window studies.
    Chang MN; Devidas M; Anderson J
    Stat Med; 2007 Jun; 26(13):2604-14. PubMed ID: 17211853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newer phase II trial designs gaining ground.
    Benowitz S
    J Natl Cancer Inst; 2007 Oct; 99(19):1428-9. PubMed ID: 17895467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.